Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation
- PMID: 12773772
- DOI: 10.1093/toxsci/kfg122
Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation
Abstract
The postnatal effects of in utero exposure to perfluorooctane sulfonate (PFOS, C8F17SO3-) were evaluated in the rat and mouse. Pregnant Sprague-Dawley rats were given 1, 2, 3, 5, or 10 mg/kg PFOS daily by gavage from gestation day (GD) 2 to GD 21; pregnant CD-1 mice were treated with 1, 5, 10, 15, and 20 mg/kg PFOS from GD 1 to GD 18. Controls received 0.5% Tween-20 vehicle (1 ml/kg for rats and 10 ml/kg for mice). At parturition, newborns were observed for clinical signs and survival. All animals were born alive and initially appeared to be active. In the highest dosage groups (10 mg/kg for rat and 20 mg/kg for mouse), the neonates became pale, inactive, and moribund within 30-60 min, and all died soon afterward. In the 5 mg/kg (rat) and 15 mg/kg (mouse) dosage groups, the neonates also became moribund but survived for a longer period of time (8-12 h). Over 95% of these animals died within 24 h. Approximately 50% of offspring died at 3 mg/kg for rat and 10 mg/kg for mouse. Cross-fostering the PFOS-exposed rat neonates (5 mg/kg) to control nursing dams failed to improve survival. Serum concentrations of PFOS in newborn rats mirrored the maternal administered dosage and were similar to those in the maternal circulation at GD 21; PFOS levels in the surviving neonates declined in the ensuing days. Small but significant and persistent growth lags were detected in surviving rat and mouse pups exposed to PFOS prenatally, and slight delays in eye opening were noted. Significant increases in liver weight were observed in the PFOS-exposed mouse pups. Serum thyroxine levels were suppressed in the PFOS-treated rat pups, although triiodothyronine and thyroid-stimulating hormone [TSH] levels were not altered. Choline acetyltransferase activity (an enzyme that is sensitive to thyroid status) in the prefrontal cortex of rat pups exposed to PFOS prenatally was slightly reduced, but activity in the hippocampus was not affected. Development of learning, determined by T-maze delayed alternation in weanling rats, was not affected by PFOS exposure. These results indicate that in utero exposure to PFOS severely compromised postnatal survival of neonatal rats and mice, and caused delays in growth and development that were accompanied by hypothyroxinemia in the surviving rat pups.
Similar articles
-
Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations.Toxicol Sci. 2003 Aug;74(2):369-81. doi: 10.1093/toxsci/kfg121. Epub 2003 May 28. Toxicol Sci. 2003. PMID: 12773773
-
Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system.Environ Sci Technol. 2009 Nov 1;43(21):8416-22. doi: 10.1021/es901602d. Environ Sci Technol. 2009. PMID: 19924978
-
Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters.Toxicology. 2005 Nov 5;215(1-2):149-69. doi: 10.1016/j.tox.2005.07.019. Epub 2005 Aug 29. Toxicology. 2005. PMID: 16129535
-
The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum.Environ Health Perspect. 2006 Nov;114(11):1776-82. doi: 10.1289/ehp.9060. Environ Health Perspect. 2006. PMID: 17107867 Free PMC article. Review.
-
The derivation of a Reference Dose (RfD) for perfluorooctane sulfonate (PFOS) based on immune suppression.Environ Res. 2019 Apr;171:452-469. doi: 10.1016/j.envres.2018.08.004. Epub 2018 Aug 8. Environ Res. 2019. PMID: 30739020 Review.
Cited by
-
Exposure to Perflouroalkyl acids and foetal and maternal thyroid status: a review.Environ Health. 2020 Oct 13;19(1):107. doi: 10.1186/s12940-020-00647-1. Environ Health. 2020. PMID: 33050930 Free PMC article. Review.
-
Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human blood.Environ Health Perspect. 2005 May;113(5):539-45. doi: 10.1289/ehp.7544. Environ Health Perspect. 2005. PMID: 15866760 Free PMC article.
-
Subchronic perfluorooctanesulfonate (PFOS) exposure induces elevated mutant frequency in an in vivo λ transgenic medaka mutation assay.Sci Rep. 2016 Dec 8;6:38466. doi: 10.1038/srep38466. Sci Rep. 2016. PMID: 27929129 Free PMC article.
-
Association between prenatal or early postnatal exposure to perfluoroalkyl substances and language development in 18 to 36-month-old children from the Odense Child Cohort.Environ Health. 2023 May 30;22(1):46. doi: 10.1186/s12940-023-00993-w. Environ Health. 2023. PMID: 37254153 Free PMC article.
-
Toxicity, uptake kinetics and behavior assessment in zebrafish embryos following exposure to perfluorooctanesulphonicacid (PFOS).Aquat Toxicol. 2010 Jun 10;98(2):139-47. doi: 10.1016/j.aquatox.2010.02.003. Epub 2010 Feb 6. Aquat Toxicol. 2010. PMID: 20171748 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical